SAN DIEGO, Jan. 5, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced that it has extended the deadline for submission of conversion notices for the first conversion date for its floating rate secured convertible notes due 2011 from December 31, 2009 to January 11, 2010.
